Cargando…

ClC5 Decreases the Sensitivity of Multiple Myeloma Cells to Bortezomib via Promoting Prosurvival Autophagy

Resistance to bortezomib (BZ) is the major problem that largely limits its clinical application in multiple myeloma treatment. In the current study, we investigated whether ClC5, a member of the chloride channel family, is involved in this process. The MTT assay showed that BZ treatment decreased ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Huimin, Pang, Yuhui, Ma, Chuanbao, Li, Jianying, Wang, Huaquan, Shao, Zonghong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cognizant Communication Corporation 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844740/ https://www.ncbi.nlm.nih.gov/pubmed/28899456 http://dx.doi.org/10.3727/096504017X15049221237147

Ejemplares similares

TRIM21 enhances bortezomib sensitivity in multiple myeloma by halting prosurvival autophagy
por: Chen, Jing, et al.
Publicado: (2023)

Autophagy: A New Mechanism of Prosurvival and Drug Resistance in Multiple Myeloma
por: Desantis, V., et al.
Publicado: (2018)

Prosurvival autophagy is regulated by protein kinase CK1 alpha in multiple myeloma
por: Carrino, Marilena, et al.
Publicado: (2019)

Cysteine Accessibility in ClC-0 Supports Conservation of the ClC Intracellular Vestibule
por: Engh, Anita M., et al.
Publicado: (2005)

Bortezomib Treatment Modulates Autophagy in Multiple Myeloma
por: Di Lernia, Giuseppe, et al.
Publicado: (2020)

ClC chloride channels
por: Mindell, Joe, et al.
Publicado: (2001)

Down-Regulation of CD9 by Methylation Decreased Bortezomib Sensitivity in Multiple Myeloma
por: Hu, Xiaotong, et al.
Publicado: (2014)

Involvement of the Tubular ClC-Type Exchanger ClC-5 in Glomeruli of Human Proteinuric Nephropathies
por: Ceol, Monica, et al.
Publicado: (2012)

NEDD4L binds the proteasome and promotes autophagy and bortezomib sensitivity in multiple myeloma
por: Huang, Xi, et al.
Publicado: (2022)

Chloride Channelopathies of ClC-2
por: Bi, Miao Miao, et al.
Publicado: (2013)

Research and progress on ClC-2
por: Wang, Hongwei, et al.
Publicado: (2017)

ClC1 chloride channel in myotonic dystrophy type 2 and ClC1 splicing in vitro
por: URSU, SIMONA-FELICIA, et al.
Publicado: (2012)

The Role of Chaperone-Mediated Autophagy in Bortezomib Resistant Multiple Myeloma
por: Nikesitch, Nicholas, et al.
Publicado: (2021)

PB2079: LACTATE DECREASES BORTEZOMIB SENSITIVITY AND PREDICTS POOR CLINICAL OUTCOMES OF MULTIPLE MYELOMA
por: MA, Naya, et al.
Publicado: (2023)

KLF4-SQSTM1/p62-associated prosurvival autophagy contributes to carfilzomib resistance in multiple myeloma models
por: Riz, Irene, et al.
Publicado: (2015)

Intracellular Proton Regulation of ClC-0
por: Zifarelli, Giovanni, et al.
Publicado: (2008)

Presenilin adopts the ClC channel fold
por: Theobald, Douglas L.
Publicado: (2016)

Nonequilibrium gating and voltage dependence of the ClC-0 Cl- channel
Publicado: (1996)

Relationship between abnormal osteoblasts and cellular immunity in multiple myeloma
por: Fu, Rong, et al.
Publicado: (2014)

Expression of GITR Enhances Multiple Myeloma Cell Sensitivity to Bortezomib
por: Zhao, Yinghao, et al.
Publicado: (2015)

The Mechanism of Fast-Gate Opening in ClC-0
por: Engh, Anita M., et al.
Publicado: (2007)

Proton block of the CLC-5 Cl(−)/H(+) exchanger
por: Picollo, Alessandra, et al.
Publicado: (2010)

Physiology and Pathophysiology of ClC-K/barttin Channels
por: Fahlke, Christoph, et al.
Publicado: (2010)

On the localization of ClC-1 in skeletal muscle fibers
por: Lamb, Graham D., et al.
Publicado: (2011)

An optical assay of the transport activity of ClC-7
por: Zanardi, Ilaria, et al.
Publicado: (2013)

Regulation of ClC-2 gating by intracellular ATP
por: Stölting, Gabriel, et al.
Publicado: (2013)

Structure of the human ClC-1 chloride channel
por: Wang, Kaituo, et al.
Publicado: (2019)

The ClC-0 chloride channel is a ‘broken’ Cl(−)/H(+) antiporter
por: Lísal, Jiří, et al.
Publicado: (2008)

The dimerization equilibrium of a ClC Cl(−)/H(+) antiporter in lipid bilayers
por: Chadda, Rahul, et al.
Publicado: (2016)

The Role of the Lysosomal Cl(−)/H(+) Antiporter ClC-7 in Osteopetrosis and Neurodegeneration
por: Zifarelli, Giovanni
Publicado: (2022)

Chloride–hydrogen antiporters ClC-3 and ClC-5 drive osteoblast mineralization and regulate fine-structure bone patterning in vitro
por: Larrouture, Quitterie C, et al.
Publicado: (2015)

Bortezomib in the management of multiple myeloma
por: Laubach, Jacob P, et al.
Publicado: (2009)

β-catenin inhibitors ICG-001 and pyrvinium sensitize bortezomib-resistant multiple myeloma cells to bortezomib
por: Wu, Cuicui
Publicado: (2022)

Solamargine induces autophagy‐mediated apoptosis and enhances bortezomib activity in multiple myeloma
por: Han, Qiaoyan, et al.
Publicado: (2022)

GlialCAM, a CLC-2 Cl(-) Channel Subunit, Activates the Slow Gate of CLC Chloride Channels
por: Jeworutzki, Elena, et al.
Publicado: (2014)

Cellular basis of ClC-2 Cl(−) channel–related brain and testis pathologies
por: Göppner, Corinna, et al.
Publicado: (2020)

ClC-3 chloride channel in hippocampal neuronal apoptosis
por: Xu, Lijuan, et al.
Publicado: (2013)

ClC-7 Deficiency Impairs Tooth Development and Eruption
por: Wang, He, et al.
Publicado: (2016)

Backbone amides are determinants of Cl(−) selectivity in CLC ion channels
por: Leisle, Lilia, et al.
Publicado: (2022)

Lycorine Downregulates HMGB1 to Inhibit Autophagy and Enhances Bortezomib Activity in Multiple Myeloma
por: Roy, Mridul, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rcbu2e2v0f9v89ag4br9e8i603